
Flex Vascular develops and markets endovascular devices for stenoses of AV fistulas and grafts and peripheral vascular disease.
flexvascular.comCrawled Oct 29, 2026
Published studies have reported that vessel preparation using kinetic endovascular controlled micro-incisions were associated with lower procedural trauma and favorable patency outcomes.
FLEX VP’s clinical evidence includes registries, peer-reviewed studies, and real-world experience for AV access and peripheral interventions.
Journal of Interventional Nephrology, 2023
The page shares news, product updates, and regulatory changes, along with industry events where the company participates.
The FLEX VESSEL PREP SYSTEM Reimbursement Guide for 2026 covers outpatient hospital reimbursement details.
N. Shammas
The page describes a website for electrical services built with Avada and WordPress to showcase expertise and services and attract clients.
FLEX VASCULAR provides contact information for inquiries and support.
The VentureMed Group Standard Terms and Conditions outline the legal terms governing transactions.
FLEX Vascular presents 12-month real-world data from its FLEX FIRST AV Registry, showing strong safety and durability of the **FLEX™ Vessel Prep System** in multi-center trials. The system reduces the need for repeat procedures (reinterventions) while maintaining patient outcomes. Early results highlight its potential for improving vascular intervention efficiency and long-term success rates.
Apr 2026PR NewswireNews article
Flex Vascular (formerly VentureMed) rebrands as the operating name for its business. The company develops the **FLEX Vessel Prep system**, a medical device used in **arteriovenous (AV) access procedures** and **peripheral arterial disease (PAD) treatment**. The name change reflects its focus on vascular interventions.
Mar 2026Vascular NewsNews article
Flex Vascular (formerly VentureMed Group) rebrands as a medical device company specializing in vessel solutions. The shift marks a streamlined identity for its vascular-focused product line. No operational changes or new product launches are announced at this stage.
Mar 2026Endovascular TodayNews article
Flex Vascular rebrands from VentureMed Group, focusing on medical devices for vessel preparation and access management in AV fistulas and related procedures. The company serves patients requiring vascular access solutions, including those with chronic kidney disease. Flex Vascular continues its mission of improving patient outcomes through innovative medical technologies.
Mar 2026PR NewswireNews article